New Drug Combination Could Prevent Head and Neck Cancer in High-Risk Patients, Emory University School of Medicine Study

A new drug combination shows promise in reducing the risk for patients with advanced oral precancerous lesions to develop squamous cell carcinoma of the head and neck. The results of the study, which included preclinical and clinical analyses, were published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Back to news